convalescent plasma treatment living meta-analysis of clinical studies

demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only

	COVID 19 outpatients
convalescent plasma treatment	CoV-Early ... C3PO CONV-ERT

5275	ILBS-COVID-02 (Bajpai M), 2020	1	1	3			high risk of bias
5405	Ahn, 2020	2	0	0	excluded		risk of bias not avaialble
5406	Duan, 2020	1	13	4		not a RCT	high risk of bias
5408	Shen, 2020	2	0	0	excluded		risk of bias not avaialble
5409	Ye, 2020	2	0	0	excluded		risk of bias not avaialble
5410	Zhang, 2020	2	0	0	excluded		risk of bias not avaialble
5411	Zhang, 2020	2	0	0	excluded		risk of bias not avaialble
5446	Sean, 2020	1	13	4		not a RCT	high risk of bias
5549	Hegerova, 2020	1	13	4		not a RCT	high risk of bias
5550	Abolghasemi, 2020	1	13	4		not a RCT	high risk of bias
5569	Dai W, 2020	2	13	4	excluded	not a RCT	high risk of bias
5662	Salazar, 2020	1	13	4		not a RCT	high risk of bias
5698	PLACID, 2020	1	1	3			high risk of bias
5717	PLACO-COVID, 2021	1	1	0			risk of bias not avaialble
5719	CPC-SARS, 2021	1	1	3			high risk of bias
5761	Joyner, 2020	1	31	3		not a RCT	high risk of bias
6159	Gemici, 2020	0	13	0	selection pending
6341	PICP19 (Ray), 2020	1	1	3			high risk of bias
6940	Bihariesingh-Sanchit (SuriCovid), 2021	1	31	0		not a RCT	risk of bias not avaialble
9112	LACCPT, 2021	1	1	0			risk of bias not avaialble
9259	Ray, 2022	0	0	0	selection pending
10178	Bargay-Lleonart, 2022	2	1	0	excluded		risk of bias not avaialble